New bufadienolides and C23 steroids from the venom of Bufo bufo gargarizans

Steroids

Volumn 75, Issue 12, 2010, Pages 884-890

  Tian, Hai Yan ^a   Wang, Lei ^b   Zhang, Xiao Qi ^b   Zhang, Dong Mei ^b   Wang, Ying ^b   Liu, Jun Shan ^b   Jiang, Ren Wang ^b   Ye, Wen Cai ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

Author keywords

Bufadienolide; Bufo bufo gargarizans; Cytotoxicity; Toad venom

Indexed keywords

(16BETA) 16 (ACETYLOXY) 14 HYDROXYLBUFA 5,20,22 TRIENOLIDE; (3BETA,16BETA) 3,16 DIHYDROXYLBUFA 8 (14),20,22 TRIENOLIDE; (3BETA,5BETA,15BETA,16BETA) 14,15 EPOXY 3,5,10,16 TETRAHYDROXYL 19 NORBUFA 20,22 DIENOLIDE; 14ALPHA ARTEBUFOGENIN; 16BETA HYDROXYLPSEUDOBUFARENOGIN; 1BETA HYDROXYLARENOBUFAGIN; 5BETA HYDROXYL 14ALPHA ARTEBUFOGENIN; BUFADIENOLIDE; BUFARENOGIN; BUFOTRICOSAROIDE A; BUFOTRICOSAROIDE B; CYTOTOXIC AGENT; PSEUDOBUFARENOGIN; STEROID; UNCLASSIFIED DRUG; VENOM;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BUFO BUFO GARGARIZANS; CANCER CELL CULTURE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; STRUCTURE ANALYSIS; TOAD; X RAY DIFFRACTION;

AMPHIBIAN VENOMS; ANIMALS; BUFANOLIDES; BUFO BUFO; CELL LINE, TUMOR; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; HUMANS; INHIBITORY CONCENTRATION 50;

ANURA; BUFO GARGARIZANS;

EID: 77955919031     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2010.05.013     Document Type: Article

References (21)

1. M.P. McGlacken, and I.J.S. Fairlamb 2-Pyrone natural products and mimetics: isolation, characterisation and biological activity Nat Prod Rep 22 2005 369 385
2. P.S. Steyn, and F.R. Van Heerdeen Bufadienolides of plant and animal origin Nat Prod Rep 15 1998 397 413
3. Y. Kamano, A. Kotake, H. Hashima, M. Inoue, H. Morita, and K. Takeya Structure-cytotoxic activity relationship for the toad poison bufadienolides Bioorg Med Chem 6 1998 1103 1115
4. Y. Kamano, A. Yamashita, T. Nogawa, H. Morita, K. Takeya, and H. Itokawa QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5 J Med Chem 45 2002 5440 5447
5. M. Ye, J. Han, D.G. An, G.Z. Tu, and D. Guo New cytotoxic bufadienolides from the biotransformation of resibufogenin by Mucor polymorphosporus Tetrahedron 61 2005 8947 8955
6. S. Hashimoto, Y. Jing, N. Kawazoe, Y. Masuda, S. Nakajo, and T. Yoshida Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs Leukemia Res 21 1997 875 883
7. K. Nobuko, W. Masahiko, M. Yutaka, N. Shigeo, and N. Kazuyasu Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells Oncogene 18 1999 2413 2421
8. P. Datta, and A. Dasgupta Effect of Chinese medicines Chan Su and Danshen on EMIT 2000 and Randox digoxin immunoassays: wide variation in digoxin-like immunoreactivity and magnitude of interference in digoxin measurement by different brands of the same product Ther Drug Monit 24 2002 637 644
9. R.J. Bick, B.J. Poindexter, R.R. Sweney, and A. Dasgupta Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na, K-ATPase blocking Life Sci 72 2002 699 709
10. H.Y. Ma, J.P. Kou, D. Zhu, Y.Q. Yan, and B.Y. Yu Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis Int Immunopharmacol 6 2006 1355 1362
11. Y. Kamano, S. Kumon, T. Arai, and M. Komatsu Bufadienolides VIII. Epimerization of 14α- and 14β-artebufogenin Chem Pharm Bull 21 1973 1960 1964
12. Y. Kamano, A. Kotake, R. Takano, H. Morita, K. Takeya, and H. Itokawa Conformational preference of two toad poison bufadienolides bufarenogin and ψ-bufarenogin Heterocycles 49 1998 275 279
13. D.M. Zhang, Y. Wang, M.K. Tang, Y.W. Chan, H.M. Lam, and W.C. Ye Saxifragifolin B from Androsace umbellate induced apoptosis on human hepatoma cells Biochem Biophys Res Commun 362 2007 759 765
14. P.M. Dewick Medicinal natural products (A biosynthetic approach) 1997 John Wiley& Sons, Ltd. West Sussex p. 241-6
15. W. Zhang, F. Xu, and H. Zhang A study of chemical constituents in dried secretion of Bufa raddei strauch Shenyang Yaoke Daxue Xuebao 9 1992 98 102
16. W.X. Li, H. Sun, Q. Li, X.Q. Zhang, W.C. Ye, and X.S. Yao Chemical components from skin of Bufo bufo gargarizans Cantor Zhongcaoyao 38 2007 183 185
17. T. Nogawa, Y. Kamano, A. Yamashita, and G.R. Pettit Isolation and structure of five new cancer cell growth inhibitory bufadienolides from the Chinese traditional drug Ch'an Su J Nat Prod 64 2001 1148 1152
18. Q. Li, W.J. Duan, Y. Yao, H. Chen, T. Liu, and Y.H. Pei Isolation and identification of bufadienolides from traditional Chinese drug Venenum Bufonis Shengyang Yaoke Daxue Xuebao 24 2007 593 614
19. M. Ye, G.Q. Qu, H.Z. Guo, and D. Guo Novel cytotoxic bufadienolides derived from bufalin by microbial hydroxylation and their structure-activity relationships J Steroid Biochem Mol Biol 91 2004 87 98
20. U. Supratman, T. Fujita, K. Akiyama, and H. Hayashi Insecticidal compounds from Kalanchoe daigremontiana × tubiflora Phytochemistry 58 2001 311 314
21. P.C. Kuo, T.H. Kuo, C.R. Su, M.J. Liou, and T.S. Wu Cytotoxic principles and a-pyrone ring-opening derivatives of bufadienolides from Kalanchoe hybrida Tetrahedron 64 2008 3392 3396